Skip to main content
. 2019 Apr 6;38(2):402–409. doi: 10.1007/s10637-019-00739-x

Table 2.

Summary of best overall response

N = 22
n (%)
Partial response (unconfirmed) 1 (5%)
Stable disease (SD) 15 (68%)a
Progressive disease (PD) 5 (23%)
Not evaluable 1
Disease control rate (CR + PR + SD) 16 (73%)

a4 patients had stable disease ≥6 months